182 related articles for article (PubMed ID: 11751331)
21. Molecular model of the alpha(IIb)beta(3) integrin.
Feuston BP; Culberson JC; Hartman GD
J Med Chem; 2003 Dec; 46(25):5316-25. PubMed ID: 14640540
[TBL] [Abstract][Full Text] [Related]
22. Insights into phenylalanine derivatives recognition of VLA-4 integrin: from a pharmacophoric study to 3D-QSAR and molecular docking analyses.
Macchiarulo A; Costantino G; Meniconi M; Pleban K; Ecker G; Bellocchi D; Pellicciari R
J Chem Inf Comput Sci; 2004; 44(5):1829-39. PubMed ID: 15446843
[TBL] [Abstract][Full Text] [Related]
23. Adenosine suppresses alpha(4)beta(7) integrin-mediated adhesion of T lymphocytes to colon adenocarcinoma cells.
MacKenzie WM; Hoskin DW; Blay J
Exp Cell Res; 2002 May; 276(1):90-100. PubMed ID: 11978011
[TBL] [Abstract][Full Text] [Related]
24. Proteolysis regulates exposure of the IIICS-1 adhesive sequence in plasma fibronectin.
Ugarova TP; Ljubimov AV; Deng L; Plow EF
Biochemistry; 1996 Aug; 35(33):10913-21. PubMed ID: 8718884
[TBL] [Abstract][Full Text] [Related]
25. Modeling and molecular dynamics of glutamine transaminase K/cysteine conjugate beta-lyase.
Venhorst J; ter Laak AM; Meijer M; van de Wetering I; Commandeur JN; Rooseboom M; Vermeulen NP
J Mol Graph Model; 2003 Sep; 22(1):55-70. PubMed ID: 12798391
[TBL] [Abstract][Full Text] [Related]
26. Annexin-V binds to the intracellular part of the beta(5) integrin receptor subunit.
Andersen MH; Berglund L; Petersen TE; Rasmussen JT
Biochem Biophys Res Commun; 2002 Mar; 292(2):550-7. PubMed ID: 11906196
[TBL] [Abstract][Full Text] [Related]
27. Structure modeling, ligand binding, and binding affinity calculation (LR-MM-PBSA) of human heparanase for inhibition and drug design.
Zhou Z; Bates M; Madura JD
Proteins; 2006 Nov; 65(3):580-92. PubMed ID: 16972282
[TBL] [Abstract][Full Text] [Related]
28. Competitive binding of vascular cell adhesion molecule-1 and the HepII/IIICS domain of fibronectin to the integrin alpha 4 beta 1.
Makarem R; Newham P; Askari JA; Green LJ; Clements J; Edwards M; Humphries MJ; Mould AP
J Biol Chem; 1994 Feb; 269(6):4005-11. PubMed ID: 7508437
[TBL] [Abstract][Full Text] [Related]
29. Multiple loop structures critical for ligand binding of the integrin alpha4 subunit in the upper face of the beta-propeller mode 1.
Irie A; Kamata T; Takada Y
Proc Natl Acad Sci U S A; 1997 Jul; 94(14):7198-203. PubMed ID: 9207068
[TBL] [Abstract][Full Text] [Related]
30. Unambiguous prediction of human integrin transmembrane heterodimer interactions using only homologous sequences.
Lin X; Tan SM; Law SK; Torres J
Proteins; 2006 Nov; 65(2):274-9. PubMed ID: 16909419
[TBL] [Abstract][Full Text] [Related]
31. Identification of putative ligand-binding sites of the integrin alpha 4 beta 1 (VLA-4, CD49d/CD29).
Kamata T; Puzon W; Takada Y
Biochem J; 1995 Feb; 305 ( Pt 3)(Pt 3):945-51. PubMed ID: 7531439
[TBL] [Abstract][Full Text] [Related]
32. Ligand binding results in divalent cation displacement from the alpha 2 beta 1 integrin I domain: evidence from terbium luminescence spectroscopy.
Dickeson SK; Bhattacharyya-Pakrasi M; Mathis NL; Schlesinger PH; Santoro SA
Biochemistry; 1998 Aug; 37(32):11280-8. PubMed ID: 9698375
[TBL] [Abstract][Full Text] [Related]
33. Crystal structure of a heparin- and integrin-binding segment of human fibronectin.
Sharma A; Askari JA; Humphries MJ; Jones EY; Stuart DI
EMBO J; 1999 Mar; 18(6):1468-79. PubMed ID: 10075919
[TBL] [Abstract][Full Text] [Related]
34. Adhesion of osteosarcoma cells to the 70-kDa core region of thrombospondin-1 is mediated by the alpha 4 beta 1 integrin.
Decker S; van Valen F; Vischer P
Biochem Biophys Res Commun; 2002 Apr; 293(1):86-92. PubMed ID: 12054567
[TBL] [Abstract][Full Text] [Related]
35. Model of the alphaLbeta2 integrin I-domain/ICAM-1 DI interface suggests that subtle changes in loop orientation determine ligand specificity.
Legge GB; Morris GM; Sanner MF; Takada Y; Olson AJ; Grynszpan F
Proteins; 2002 Aug; 48(2):151-60. PubMed ID: 12112684
[TBL] [Abstract][Full Text] [Related]
36. A region of the integrin VLA alpha 4 subunit involved in homotypic cell aggregation and in fibronectin but not vascular cell adhesion molecule-1 binding.
Muñoz M; Serrador J; Sánchez-Madrid F; Teixidó J
J Biol Chem; 1996 Feb; 271(5):2696-702. PubMed ID: 8576243
[TBL] [Abstract][Full Text] [Related]
37. Talin controls integrin activation.
Calderwood DA
Biochem Soc Trans; 2004 Jun; 32(Pt3):434-7. PubMed ID: 15157154
[TBL] [Abstract][Full Text] [Related]
38. A tumor-associated beta 1 integrin mutation that abrogates epithelial differentiation control.
Evans RD; Perkins VC; Henry A; Stephens PE; Robinson MK; Watt FM
J Cell Biol; 2003 Feb; 160(4):589-96. PubMed ID: 12578911
[TBL] [Abstract][Full Text] [Related]
39. Talin binding to integrin beta tails: a final common step in integrin activation.
Tadokoro S; Shattil SJ; Eto K; Tai V; Liddington RC; de Pereda JM; Ginsberg MH; Calderwood DA
Science; 2003 Oct; 302(5642):103-6. PubMed ID: 14526080
[TBL] [Abstract][Full Text] [Related]
40. Identity of the amino acid residues involved in C3bi binding to the I-domain supports a mosaic model to explain the broad ligand repertoire of integrin alpha M beta 2.
Ustinov VA; Plow EF
Biochemistry; 2005 Mar; 44(11):4357-64. PubMed ID: 15766265
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
